Safety and feasibility of low‐dose ticagrelor in patients with ST‐segment elevation myocardial infarction

BACKGROUND: Previous studies have confirmed the safety and feasibility of half‐dose ticagrelor in Chinese patients with acute coronary syndrome, but currently there is no plan for the use of ticagrelor for Chinese ST‐segment elevation myocardial infarction (STEMI) patients. HYPOTHESIS: It is safe an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanbo, Jiang, Yunfa, Zhi, Wei, Fu, Yang, Wang, Qing, Zhou, Jianli, Zheng, Shaochen, Hao, Guozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803363/
https://www.ncbi.nlm.nih.gov/pubmed/33320381
http://dx.doi.org/10.1002/clc.23517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803363/
https://www.ncbi.nlm.nih.gov/pubmed/33320381
http://dx.doi.org/10.1002/clc.23517

Ejemplares similares